Conclusions::
Both patient groups show a similar VA deterioration and progressiverod-done dysfunction. Macular changes seem to be more presentamong patients with BBS1 mutations, which might be biased bythe higher age in this group. The ocular phenotype and the naturalhistory do not differ significantly between patients with BBS1and patients with BBS10 mutations.